NCT00380796
- Conditions
- COPD, Chronic Disease, Disease Attributes, +6 more
- Locations
-
- Anaheim, California, United States
- San Diego, California, United States
- Bay Pines, Florida, United States
- Clearwater, Florida, United States
Clinical trial condition
Pulmonary Disease, Chronic Obstructive
Explore clinical trials studying Pulmonary Disease, Chronic Obstructive. Study availability and eligibility vary by location and protocol.
4,003 public trials
391 recruiting studies
Pulmonary Disease, Chronic Obstructive trial results
NCT01118936
- Conditions
- COPD, Chronic Disease, Disease Attributes, +6 more
- Locations
-
- Research Dept. of Respiratory Medicine, Aarhus University Hospital Aarhus C, Denmark
NCT01636401
- Conditions
- COPD, Chronic Disease, Disease Attributes, +6 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT01331070
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +6 more
- Locations
-
- Hôpital Bichat Paris, France
Completed
QVA149 Versus Fluticasone/Salmeterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
NCT01315249
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +6 more
- Locations
-
- Novartis Investigative Site Malmedy, Belgium
- Novartis Investigative Site Luxembourg, Belgium
- Novartis Investigative Site Aalst, Belgium
- Novartis Investigative Site Brussels, Belgium
NCT01391559
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +10 more
- Locations
-
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
Completed
Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers
NCT01690949
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease (COPD), Disease Attributes, +8 more
- Locations
-
- Fraunhofer Institut fur Toxicologie und Experimentelle Medicine (ITEM) Hanover, Germany
NCT01580423
- Conditions
- Chronic Disease, Chronic Obstructive Pulmonary Disease, Disease Attributes, +10 more
- Locations
-
- Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States
NCT00281203
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- University of Michigan at Ann Arbor Ann Arbor, Michigan, United States
- Conditions
- Chronic Disease, Disease Attributes, Lung Diseases, +5 more
- Locations
-
- Pfizer Investigational Site Mobile, Alabama, United States
- Pfizer Investigational Site Glendale, Arizona, United States
- Pfizer Investigational Site San Diego, California, United States
- Pfizer Investigational Site Clearwater, Florida, United States